In EGFR-dependent cancers of multiple cell lineages, FGFR3-TACC3 fusion proteins are also characterised as “naturally occurring drivers of tumour resistance” by reactivating EGFR/ERK signalling [201]. This evidence concerns the gene FGFR3 and neoplasm.